The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 VG in patients with melanoma.
 
Rachel Lubong Sabado
No Relationships to Disclose
 
Anna C. Pavlick
Speakers' Bureau - Bristol-Myers Squibb
 
Sacha Gnjatic
Consulting or Advisory Role - Boehringer Ingelheim; Third Rock Ventures
Research Funding - Advaxis; Immune Design; Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Ludwig Institute for Cancer Research
 
Farah Hasan
No Relationships to Disclose
 
Meredith Spadaccia
No Relationships to Disclose
 
Bike Su Oner
No Relationships to Disclose
 
Hanqing Dong
No Relationships to Disclose
 
Rose Marie Holman
Employment - Oncovir
 
Isabelita Vengco
Employment - Novartis
 
Caroline Muren
No Relationships to Disclose
 
Crystal Escano
No Relationships to Disclose
 
Ethel Yepes
No Relationships to Disclose
 
Claire Stein
No Relationships to Disclose
 
Achim A Jungbluth
Employment - Ludwig Institute for Cancer Research
 
Linda S. Pan
No Relationships to Disclose
 
Ralph Rudolph Venhaus
Stock and Other Ownership Interests - Agenus; Dynavax Technologies; Soligenix
 
Andres M. Salazar
Employment - Oncovir
Leadership - Oncovir
Stock and Other Ownership Interests - Oncovir
Research Funding - Oncovir
Patents, Royalties, Other Intellectual Property - Oncovir
Travel, Accommodations, Expenses - Oncovir
 
Patrick Alexander Ott
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - ARMO BioSciences; Bristol-Myers Squibb; Merck
 
Nina Bhardwaj
No Relationships to Disclose